Drugs / PD-1 inhibitor
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 3 | NCT05374252 Background | May 2022 → May 2025 | anal canal cancer, anal squamous cell carcinoma | Sixth Affiliated Hospital, Sun Yat-sen University | Unknown | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | PD-1 inhibitor | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05374252 ↗ |